Аnaplastic large cell lymphoma, аssociated with the mammary gland implants


Abstract

Аnaplastic large cell lymphoma, аssociated with the mammary gland implants

References

1. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569.

2. ASPS National Clearinghouse of Plastic Surgery Procedural Statistics 2016. Available from: https://d2wirczt3b6wjm.cloudfront.net/News/Statistics/2016/2016-plastic-surgery-statisticsreport. pdf.

3. International Society of Aesthetic Plastic Surgery Global Statistics. 2016. Available from: https://www.isaps.org/wp-content/uploads/2017/10/GlobalStatistics2016-1.pdf.

4. U.S. Food and Drug Administration. Anaplastic large cell lymphoma (ALCL) in women with breast implants. Medical device reports of breast implant-associated anaplastic large cell lymphoma. Available from: https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ ImplantsandProsthetics/BreastImplants/ucm481899.htm.

5. Breast implant-associated anaplastic large cell lymphomas. An experts opinion. The French National Cancer Institute. Available from: http://www.ecancer.fr/content/download/119635/1429833/file/Breast implant-associated anaplastic large cell lymphomas.pdf.

6. Campanale A, Boldrini R, Marletta M. 22 Cases of Breast Implant-Associated ALCL: Awareness and Outcome Tracking from the Italian Ministry of Health. Plast Reconstr Surg. 2018 Jan;141(1):11e-19e. doi: 10.1097/PRS.0000000000003916.

7. Medicines & Health care products Regulatory Agency. Breast implants and Anaplastic Large Cell Lymphoma (ALCL). Available from: https://www.gov.uk/guidance/breast-implants-and-anaplastic-large-cell-lymphoma-alcl.

8. Australian Government. TGA. Update - additional confirmed cases of anaplastic large cell lymphoma. Available from: https://www.tga.gov.au/alert/breast-implants-and-anaplastic-large-cell-lymphoma.

9. Loch-Wilkinson A, Beath KJ, Knight RJW, Wessels WLF, Magnusson M, Papadopoulos T, et al. Breast Implant–Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand: High-Surface-Area Textured Implants Are Associated with Increased Risk. Plast Reconstr Surg. 2017 Oct;140(4):645-54. doi: 10.1097/PRS.0000000000003654.

10. de Boer M, van Leeuwen FE, Hauptmann M, Overbeek LIH, de Boer JP, Hijmering NJ, et al. Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast. JAMA Oncol. Accepted for Publication: 2017 October 10. Published Online: 2018 January 4. Available from: https://www.nvpc.nl/Uploads/jamaoncology_de_Boer_2018_oi_170081.pdf. doi: 10.1001/jamaoncol.2017.4510.

11. Brody GS, Deapen D, Taylor CR, Pinter-Brown L, House-Lightner SR, Andersen JS, et al. Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg. 2015 Mar;135(3):695-705. doi: 10.1097/PRS.0000000000001033.

12. Clemens M. BIA-ALCL Resources By the numbers, and what they mean. 2018 March 21. Available from: https://www.plasticsurgery.org/for-medical-professionals/health-policy/bia-alcl-physician-resources/by-the-numbers.

13. Adrada BE, Miranda RN, Rauch GM, Arribas E, Kanagal-Shamanna R, Clemens MW, et al. Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients. Breast Cancer Res Treat. 2014 Aug;147(1):1-14. doi: 10.1007/s10549-014-3034-3.

14. Kadin ME, Deva A, Xu H, Morgan J, Khare P, MacLeod RA, et al. Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2016 Jul;36(7):773-81. doi: 10.1093/asj/sjw023.

15. Clemens MW, Horwitz SM. NCCN Consensus Guidelines for the Diagnosis and Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2017 Mar 1;37(3):285-9. doi: 10.1093/asj/sjw259.

16. Kim B, Predmore ZS, Mattke S, van Busum K, Gidengil CA, et al. Breast implant-associated anaplastic large cell lymphoma: updated results from a structured expert consultation process. Plast Reconstr Surg Glob Open. 2015 Feb 6;3(1):e296. doi: 10.1097/GOX.0000000000000268.

17. Aladily TN, Medeiros LJ, Amin MB, Haideri N, Ye D, Azevedo SJ, et al. Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases. Am J Surg Pathol. 2012 Jul;36(7):1000-8. doi: 10.1097/PAS.0b013e31825749b1.

18. Horwitz SM, Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, et al. NCCN guidelines insights: Non-Hodgkin’s lymphomas, version 3.2016. J Natl Compr Canc Netw. 2016 Sep;14(9):1067-79.

19. Zimmerman A, Locke FL, Emole J, Rosa M, Horna P, Hoover S, et al. Recurrent systemic anaplastic lymphoma kinase-negative anaplastic large cell lymphoma presenting as a breast implant-associated lesion. Cancer Control. 2015 Jul;22(3):369-73. doi: 10.1177/107327481502200317.

20. Johnson L, O’Donoghue J, Stark H, McLean N, Turton P, Khan AA, Turner SD, et al. Breast implant associated anaplastic large cell lymphoma (BIA-ALCL): The UK experience and first reported case of neoadjuvant brentuximab. Cancer Res. 2017;77(Suppl):Abstract P5-03-02. doi: 10.1158/1538-7445.

21. Richardson K, Alrifai T, Grant-Szymanski K, Kouris GJ, Venugopal P, Mahon B, et al. Breast implant-associated anaplastic large-cell lymphoma and the role of brentuximab vedotin (SGN-35) therapy: A case report and review of the literature. Molecular and Clinical Oncology. 2017;6(4):539–42. doi: 10.3892/mco.2017.1170.

Author Biographies


I. M. Motuziuk, Bogomolets National Medical University, Kyiv,

Igor Motuziuk MD, PhD (Med), Assistant Professor

Oncology Department

Bogomolets National Medical University

03022, 33/43 Lomonosova Street, Kyiv, Ukraine

cell: +38 067 719 99 22,

e-mail: 180978igor@gmail.com

https://orcid.org/0000-0002-8332-3280


O. I. Sydorchuk, Bogomolets National Medical University, Kyiv,

Oleg Sydorchuk – MD, PhD (Med), Associate Professor

Oncology Department

Bogomolets National Medical University

03022, 33/43 Lomonosova Street, Kyiv, Ukraine

cell: +38 097 371 85 76,

e-mail: oleg.sydorchuk0@gmail.com

https://orcid.org/0000-0002-6209-1353


M. S. Krotevych, National Cancer Institute, Kyiv

Mykhailo Krotevych – MD, PhD (Med),

Chief of Pathology Department

National Cancer Institute

03022, 33/43 Lomonosova Street, Kyiv, Ukraine

cell: +38 050 196 79 86 ,

e-mail: morfolog@ukr.net

https://orcid.org/0000-0002-5228-7491


P. L. Poniatovskyi, Bogomolets National Medical University, Kyiv,

Petro Poniatovskyi – Student (Med)

Oncology Department

Bogomolets National Medical University              

03022, 33/43 Lomonosova Street, Kyiv, Ukraine

cell: +38 067 311 80 55,

e-mail: poniatovskyi.petro@gmail.com

https://orcid.org/0000-0002-0047-6928


E. V. Kostiuchenko, Bogomolets National Medical University, Kyiv,

Yevhenii Kostiuchenko – MD, PhD (Med) student, Assistant Professor

Oncology Department

Bogomolets National Medical University

03022, 33/43 Lomonosova Street, Kyiv, Ukraine

cell: +38 099 282 62 73,

e-mail: yekostiuchenko@gmail.com

https://orcid.org/0000-0001-9218-0050

Published
2018-12-28
How to Cite
Motuziuk, I. M., Sydorchuk, O. I., Krotevych, M. S., Poniatovskyi, P. L., & Kostiuchenko, E. V. (2018). Аnaplastic large cell lymphoma, аssociated with the mammary gland implants. Klinicheskaia Khirurgiia, 85(12), 72-74. https://doi.org/10.26779/2522-1396.2018.12.72